2-{(E)-[(2-Hydroxy-1-naphthyl)methylene]amino}-N-(1-phenylethyl)benzamide(CAS: 410536-97-9)

This compound falls under various regulatory frameworks such as REACH in Europe, which requires registration, evaluation, authorization, and restriction of chemicals. In the US, it may be subject to FDA regulations for pharmaceutical use and EPA regulations for environmental impacts. GHS (Globally Harmonized System) classification will determine its hazardous properties and appropriate safety data sheets (SDS) will be required.

Synthetic alternatives might include analogous compounds like 2-{(E)-[(2-hydroxy-1-naphthyl)methylene]amino}-N-(1-phenylethyl)benzamide isomers, or use of different amine or benzamide derivatives. Common reagents for similar syntheses include diethylamine, morpholine, or various aromatic amines, which can offer comparable functional groups and reactivity.

Market trends suggest increasing interest in this compound due to its potential in pharmaceutical applications and as a receptor modulator. Research is focusing on its therapeutic potential in treating neurological disorders, making it a key ingredient in ongoing drug development projects. Price trends indicate stable demand with moderate to high pricing.

Waste containing this compound should be collected in appropriate containers and disposed of through incineration or professional chemical waste disposal services. Environmental protection measures include ensuring containment to prevent leaks and proper labeling for hazardous waste. Regulatory compliance ensures adherence to local and international environmental regulations.